Search Results - Yimer, Getnet
- Showing 1 - 9 results of 9
-
1
Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients by Aklillu, Eleni (Author) , Zumla, Alimuddin (Author) , Habtewold, Abiy (Author) , Amogne, Wondwossen (Author) , Makonnen, Eyasu (Author) , Yimer, Getnet (Author) , Burhenne, Jürgen (Author) , Diczfalusy, Ulf (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Impact of population and pharmacogenetics variations on efavirenz pharmacokinetics and immunologic outcomes during anti-tuberculosis co-therapy: a parallel prospective cohort study... by Mugusi, Sabina (Author) , Habtewold, Abiy (Author) , Ngaimisi, Eliford (Author) , Amogne, Wondwossen (Author) , Yimer, Getnet (Author) , Minzi, Omary (Author) , Makonnen, Eyasu (Author) , Sudfeld, Christopher (Author) , Burhenne, Jürgen (Author) , Aklillu, Eleni (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: a prospective cohort study by Nylén, Hanna (Author) , Habtewold, Abiy (Author) , Makonnen, Eyasu (Author) , Yimer, Getnet (Author) , Bertilsson, Leif (Author) , Burhenne, Jürgen (Author) , Diczfalusy, Ulf (Author) , Aklillu, Eleni (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
SLCO1B1 gene variations among Tanzanians, Ethiopians, and Europeans: relevance for African and worldwide precision medicine by Aklillu, Eleni (Author) , Habtewold, Abiy (Author) , Ngaimisi, Eliford (Author) , Yimer, Getnet (Author) , Mugusi, Sabina (Author) , Amogne, Wondwossen (Author) , Reuter, Tasmin (Author) , Meid, Andreas (Author) , Hoffmann, Michael Marcus (Author) , Weiß, Johanna (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
5
Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa?: the HIV-TB pharmagene study by Habtewold, Abiy (Author) , Makonnen, Eyasu (Author) , Amogne, Wondwossen (Author) , Yimer, Getnet (Author) , Aderaye, Getachew (Author) , Bertilsson, Leif (Author) , Burhenne, Jürgen (Author) , Aklillu, Eleni (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
6
Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa popula... by Ngaimisi, Eliford (Author) , Habtewold, Abiy (Author) , Minzi, Omary (Author) , Makonnen, Eyasu (Author) , Mugusi, Sabina (Author) , Amogne, Wondwossen (Author) , Yimer, Getnet (Author) , Riedel, Klaus-Dieter (Author) , Janabi, Mohammed (Author) , Aderaye, Getachew (Author) , Mugusi, Ferdinand (Author) , Bertilsson, Leif (Author) , Aklillu, Eleni (Author) , Burhenne, Jürgen (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
7
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort... by Yimer, Getnet (Author) , Haefeli, Walter E. (Author) , Burhenne, Jürgen (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
8
Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients by Habtewold, Abiy (Author) , Amogne, Wondwossen (Author) , Makonnen, Eyasu (Author) , Yimer, Getnet (Author) , Riedel, Klaus-Dieter (Author) , Ueda, Nobuhisa (Author) , Worku, Alemayehu (Author) , Haefeli, Walter E. (Author) , Lindquist, Lars (Author) , Aderaye, Getachew (Author) , Burhenne, Jürgen (Author) , Aklillu, Eleni (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
9
Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients by Yimer, Getnet (Author) , Ueda, Nobuhisa (Author) , Habtewold, Abiy (Author) , Amogne, Wondwossen (Author) , Suda, Akira (Author) , Riedel, Klaus-Dieter (Author) , Burhenne, Jürgen (Author) , Aderaye, Getachew (Author) , Lindquist, Lars (Author) , Makonnen, Eyasu (Author) , Aklillu, Eleni (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
HIV
Africa
Antiretroviral therapy
Tuberculosis
4β-hydroxycholesterol
African people
Alleles
CYP2B6
CYP3A
Drug metabolism
Enzyme metabolism
Highly-active antiretroviral therapy
Isoniazid
Medical risk factors
Pharmacaeconomics
Pharmacogenetics
Pharmacokinetics
Population genetics
Population variation
co-infection
drug-drug interaction
efavirenz
enzyme induction
rifampicin
tuberculosis